Cargando…

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection

The immune response to SARS-CoV-2 is critical in controlling disease but there is concern that waning immunity may predispose to re-infection. We analysed the magnitude and phenotype of the SARS-CoV-2-specific T cell response in 100 donors at six months following infection. T-cell responses were pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Jianmin, Dowell, Alexander C., Pearce, Hayden, Verma, Kriti, Long, Heather M., Begum, Jusnara, Aiano, Felicity, Amin-Chowdhury, Zahin, Hallis, Bassam, Stapley, Lorrain, Borrow, Ray, Linley, Ezra, Ahmad, Shazaad, Parker, Ben, Horsley, Alex, Amirthalingam, Gayatri, Brown, Kevin, Ramsay, Mary E., Ladhani, Shamez, Moss, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610739/ https://www.ncbi.nlm.nih.gov/pubmed/33674800 http://dx.doi.org/10.1038/s41590-021-00902-8

Ejemplares similares

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
por: Aiano, Felicity, et al.
Publicado: (2023)

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
por: Dowell, Alexander C., et al.
Publicado: (2021)

SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
por: Ladhani, Shamez N., et al.
Publicado: (2021)

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
por: Ladhani, Shamez N, et al.
Publicado: (2021)

Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
por: Ireland, Georgina, et al.
Publicado: (2021)

Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England
por: Powell, Annabel A., et al.
Publicado: (2022)

Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study
por: Aiano, Felicity, et al.
Publicado: (2021)

COVID-19 vaccine given to children with comorbidities in England, December 2020–June 2021
por: Aiano, Felicity, et al.
Publicado: (2022)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Implementation of preventive measures to prevent COVID-19: a national study of English primary schools in summer 2020
por: Sundaram, Neisha, et al.
Publicado: (2021)

Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
por: Parry, Helen, et al.
Publicado: (2021)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection
por: Thelwall, Simon, et al.
Publicado: (2022)

COVID-19 in children: analysis of the first pandemic peak in England
por: Ladhani, Shamez N, et al.
Publicado: (2020)

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Extended interval BNT162b2 vaccination enhances peak antibody generation
por: Parry, Helen, et al.
Publicado: (2022)

Association of Spike-Specific T Cells With Relative Protection From Subsequent SARS-CoV-2 Omicron Infection in Young Children
por: Dowell, Alexander C., et al.
Publicado: (2022)

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study)
por: Stephenson, Terence, et al.
Publicado: (2021)

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
por: Jeffery-Smith, Anna, et al.
Publicado: (2021)

COVID-19 outbreaks following full reopening of primary and secondary schools in England: Cross-sectional national surveillance, November 2020
por: Aiano, Felicity, et al.
Publicado: (2021)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
por: Oeser, C, et al.
Publicado: (2023)

PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity
por: Parry, Helen M., et al.
Publicado: (2021)

Parents’ and teachers’ attitudes to and experiences of the implementation of COVID-19 preventive measures in primary and secondary schools following reopening of schools in autumn 2020: a descriptive cross-sectional survey
por: Amin-Chowdhury, Zahin, et al.
Publicado: (2022)

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England
por: Powell, Annabel A, et al.
Publicado: (2021)

Enter B and W: two new meningococcal vaccine programmes launched
por: Ladhani, Shamez N, et al.
Publicado: (2016)

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
por: Dowell, Alexander C., et al.
Publicado: (2022)

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022
por: Ladhani, Shamez N, et al.
Publicado: (2022)

Nucleocapsid-Specific Antibodies as a Correlate of Protection against SARS-CoV-2 Reinfection in Children
por: Dowell, Alexander C., et al.
Publicado: (2023)

The Cellular Localization of Human Cytomegalovirus Glycoprotein Expression Greatly Influences the Frequency and Functional Phenotype of Specific CD4(+) T Cell Responses
por: Pachnio, Annette, et al.
Publicado: (2015)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hre1ve26rrn5efuv8cd808nlqa